Ipratropium bromide 0.5 mg/3 mL (0.017%), albuterol (as sulfate) 2.5 mg/3 mL (0.083%); soln for inh. Not for primary treatment of acute attack. Avoid excessive use. Discontinue if paradoxical ...

This leaflet answers some common questions about Atrovent Inhalation Solution. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

This leaflet answers some common questions about Atrovent UDV. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...

Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...

Any Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Read on to find out more ...

Another colleague sees the agony in your face and offers to help. She offers you her generic acetaminophen bottle, and a part of you panics, thinking it might not be as effective as your cherished ...

Seated on drug-store shelves right next to most brand-name medications is the generic version of the drug and Claritin is no ...

Oct 16 (Reuters) - Novartis (NOVN.S), opens new tab has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by blocking regulators from ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1. And for every success, there are nine drug candidates that fail clinical trials 2.

Although there is much to celebrate regarding our heritage in respiratory diseases – spanning almost 100 years of innovation in drug and device development – there is continuing medical need ...